Pfizer Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€32.40
Target price
02.08.24
€40.22
Performance (%)
-14.02%
Price
18:12
€26.32
Summary
This prediction is currently active. The price of Pfizer Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.02%. A total of €1.54 was paid as dividends for this prediction. This prediction currently runs until 02.08.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 2.110% | 2.110% |
| iShares Core DAX® | -0.051% | 4.829% |
| iShares Nasdaq 100 | 1.659% | 2.417% |
| iShares Nikkei 225® | 0.658% | -2.173% |
| iShares S&P 500 | 0.964% | 2.547% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat